Leading ad tech innovators and thought leaders from companies including Publicis Health Media, LiveRamp, VAB, FreeWheel, DoubleVerify, LG Ads Solutions, and more joined DeepIntent to discuss the opportunities available to pharma marketers with CTV
DeepIntent's exclusive May 5 event explored important topics including reaching patient audiences with precision, CTV identity resolution, and effective measurement with ACR data
NEW YORK, May 9, 2022 /PRNewswire/ — Healthcare advertising technology company DeepIntent hosted a first-of-its-kind summit for pharma marketers featuring a dynamic mix of insightful keynotes, panels, and fireside chats on the future of connected TV (CTV) in pharma advertising this past Thursday.
DeepIntent's “Innovating with Intent” summit showcased an exclusive crowd of advertising technology innovators and thought leaders from CTV trailblazers including Matterkind, LG Ads Solutions, Integral Ad Science, Magnite, Oracle, DoubleVerify, ID5, LiveRamp, TransUnion, Publicis Health Media, FreeWheel, the Video Advertising Bureau (VAB), and more.
“CTV is the new brand battlefield. It's a war that will be fought with technology and data. The pharma brands who seize the opportunity to lean in, test and learn, and build relationships with innovative partners will be the best positioned to outcompete and outperform their competition,” said Chris Paquette, Founder and CEO at DeepIntent, who delivered the keynote about the State of Pharma CTV.
As previously reported, DeepIntent has seen a 25-fold increase in CTV investment on its platform by healthcare and pharmaceutical companies over the last year, with many pharma marketers gradually shifting budgets from linear to CTV to extend the incremental reach of their advertising campaigns. The summit sought to highlight important topics for pharma marketers at the forefront of this movement, such as reaching patient audiences with precision, CTV identity resolution, and effective…